Land(mark) ahoy: PFS24 in relapsed/refractory diffuse large B-cell lymphoma

Affiliations

Free article

Comment

Matthew Matasar. Transplant Cell Ther. 2022 Sep.

Free article

. 2022 Sep;28(9):521-522.

doi: 10.1016/j.jtct.2022.08.004.

¹ Associate Member, Lymphoma Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065.

No abstract available

Comment on

Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
Tun AM, Maliske S, Wang Y, Inwards DJ, Habermann TM, Micallef I, Porrata L, Paludo J, Bisneto JV, Rosenthal A, Kharfan-Dabaja MA, Ansell SM, Nowakowski GS, Farooq U, Johnston PB. Tun AM, et al. Transplant Cell Ther. 2022 Sep;28(9):610-617. doi: 10.1016/j.jtct.2022.06.015. Epub 2022 Jun 22. Transplant Cell Ther. 2022. PMID: 35752441